Radiation enhancement of cetuximab on human breast adenoma MDA-MB-231 cells line

Chinese Journal of Cancer Prevention and Treatment

Volumn 20, Issue 12, 2013, Pages 898-903

  Yao, Jian Xin ^a   Yao, Zhi Feng ^a,b   Liu, Yong Biao ^a  

^a Nanjing Health School of Jiangsu Union Technical Institute   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasms; Cetuximab; Epidermal growth factor receptor; Radiosensitivity

Indexed keywords

CETUXIMAB;

APOPTOSIS; ARTICLE; BREAST ADENOMA; CANCER CELL CULTURE; CELL COUNT; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLONOGENIC ASSAY; CONCENTRATION (PARAMETERS); DRUG ACCUMULATION; DRUG INHIBITION; FOLLOW UP; HUMAN; HUMAN CELL; IN VITRO STUDY; LETHAL DOSE; RADIOSENSITIVITY;

EID: 84886891384     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. 2012, 19(12): 157-160.
2. Krause M, Prager J, Zhou X, et al. EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: Differential response of cancer stem cells and nontumourigenic cells? [J]. Radiother Oncol, 2007, 83(3): 316-325.
3. 2007, 14(5): 450-454.
4. Diaz Miqueli A, Rolff J, Lemm M, et al. Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies[J]. Br J Cancer, 2009, 100(6): 950-958.
5. Rades D, Wolff C, Nadrowitz R, et al. Radioactive EGFR antibody cetuximab in multimodal cancer treatment: stability and synergistic effects with radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2009, 75(4): 1226-1231.
6. 2004, 7(3): 191-194.
7. 1998: 952-953.
8. 2012, 32(4): 354-357.
9. 2012, 32(5): 481-484.
10. Zhang YD, Wang JJ, Liu F, et al. EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells[J]. Cancer Cell Int, 2010, 10(39): 1-7.
11. Liu F, Wang JJ, You ZY, et al. Radiosensitivity of prostate cancer cells is enhanced by EGFR inhibitor C225[J]. Urol Oncol, 2010, 28(1): 59-66.
12. 2011, 18(4): 260-263.
13. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2004, 59(4): 928-942.
14. 2012, 19(1): 41-44.
15. 2011, 38(4): 373-376.
16. Huang SM, Rock JM, Harari PM, et al. Epidermal growth factor receptor blockade with C225 modulates proliferation. apoptosis, and radioeensitivity in squslnous cell carcinomas of the head and neck[J]. Cancer Res, 1999, 59(8): 1935-1940.
17. Oleg T, Graham C. Bax activation and translocation to mitochondria mediate EGF-induced programmed cell death [J]. J Cell Sci, 2005, 118(Pt24): 5681-5690.
18. Sclabas GM, Fujioka S, Sehmidt C, et al. Restoring apoptosis in pancreatic cancer cells by targeting the nuclear faetor-kappaB signaling pathway with the anti-epidermal growth factor antibody IMC-C225[J]. J Gastrointest Surg, 2003, 7(1): 3743.